Sumitomo Pharma America IS COMMITTED TO IMPROVING ACCESS TO GEMTESA

GEMTESA is covered for 69% of national commercial plans and covered for 85% of Medicare Part D Lives*

For more information, please contact your GEMTESA Sales Representative.

All formulary data and access criteria are provided by Managed Markets Insights & Technology, LLC database as of October 2023. Nothing on this website is intended to serve as a guarantee of coverage or a guarantee of payment. For verification of coverage, please contact insurance plan.

*National commercial health plan formulary status under the pharmacy benefit updated as of October 2023.

Data on file. Sumitomo Pharma America, Inc.

Patient Connect Support logo.

Personalized support for the GEMTESA treatment journey through:

  • Tools that improve access to GEMTESA
  • Resources that identify payor coverage among patients with OAB in the practice
  • Insights for the office to help those who have a more challenging pathway to coverage
  • Identification and addressing of barriers patients experience with regard to obtaining their prescribed medication, overcoming financial challenges, and getting started — and staying — on therapy
Visit our library of resources available to support providers and staff as they navigate treatment with GEMTESA